Evidence map›Paper›PMID 28776111›Full record

ArticleLasers in medical science2017

Methylene blue mediated photobiomodulation on human osteoblast cells.

Gamze Bölükbaşı Ateş, Ayşe Ak, Bora Garipcan, Murat Gülsoy

Abstract read
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Gamze Bölükbaşı AteşInstitute of Biomedical Engineering, Bogazici University, Uskudar, 34684, Istanbul, Turkey. gbolukbasi@boun.edu.tr.ORCID http://orcid.org/0000-0003-0484-1096
Ayşe AkEngineering Faculty, Biomedical Engineering, Erzincan University, 24100, Erzincan, Turkey.
Bora GaripcanInstitute of Biomedical Engineering, Bogazici University, Uskudar, 34684, Istanbul, Turkey.
Murat GülsoyInstitute of Biomedical Engineering, Bogazici University, Uskudar, 34684, Istanbul, Turkey.
Boğaziçi University · TRErzincan Binali Yıldırım University · TRÜsküdar University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photobiomodulation (PBM) and photodynamic therapy (PDT) are two major methods, which use light in medicine and dentistry. PBM uses low-level laser light to induce cell proliferation and activity. In contrast, PDT use laser light combined with a photosensitizer (PS) to cause cell death. Due to similar, not fully understood mechanisms and biphasic response of light, unexpected and complex outcomes may be observed. In the present study, the effect of 635 nm laser light, with power density 50 mW/cm

Indexed as

Alkaline PhosphataseCalcification, PhysiologicCell LineCell ProliferationCell SurvivalGene Expression RegulationHumansLasersLow-Level Light TherapyMethylene BlueOsteoblastsStaining and LabelingAlkaline PhosphataseMethylene Blue635 nmLow-level laser therapy (LLLT)Methylene blueOsteoblastPhotobiomodulation (PBM)Photodynamic therapy (PDT)

Identifiers

PMID28776111
OpenAlexW2744693475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.